Thioredoxin Systems Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.4M

  • Investors
  • 6

Thioredoxin Systems General Information

Description

Developer of pharmaceutical products designed for the treatment of multidrug-resistant infections. The company's technology utilizes a combination of silver ions and ebselen to disable bacterial thioredoxin enzyme systems, enabling healthcare providers to use a bactericidal antibiotic that treats urinary tract infections without triggering cross-resistance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nanna Svartz Väg 2
  • Solna
  • 171 65 Stockholm
  • Sweden
+46
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Nanna Svartz Väg 2
  • Solna
  • 171 65 Stockholm
  • Sweden
+46

Thioredoxin Systems Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Thioredoxin Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 30-Oct-2024 $2.4M Completed Generating Revenue
1. Later Stage VC 31-Dec-2022 Completed Startup
To view Thioredoxin Systems’s complete valuation and funding history, request access »

Thioredoxin Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Thioredoxin Systems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Thioredoxin Systems Patents

Thioredoxin Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10653717-B2 Antibiotic compositions Active 05-Dec-2016
US-11801262-B2 Antibiotic compositions Active 05-Dec-2016
US-20180185410-A1 Antibiotic compositions Active 05-Dec-2016
US-20200281967-A1 Antibiotic compositions Active 05-Dec-2016
AU-2017374015-A1 Antibiotic compositions comprising silver and selenium Active 05-Dec-2016 A61K33/04
To view Thioredoxin Systems’s complete patent history, request access »

Thioredoxin Systems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Thioredoxin Systems Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Annexstruktur AB Corporate Venture Capital Minority
GOBIA Enterprises Venture Capital Minority
GU Ventures Accelerator/Incubator Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 6 investors. Get the full list »

Thioredoxin Systems FAQs

  • When was Thioredoxin Systems founded?

    Thioredoxin Systems was founded in 1994.

  • Where is Thioredoxin Systems headquartered?

    Thioredoxin Systems is headquartered in Stockholm, Sweden.

  • What is the size of Thioredoxin Systems?

    Thioredoxin Systems has 9 total employees.

  • What industry is Thioredoxin Systems in?

    Thioredoxin Systems’s primary industry is Drug Discovery.

  • Is Thioredoxin Systems a private or public company?

    Thioredoxin Systems is a Private company.

  • What is Thioredoxin Systems’s current revenue?

    The current revenue for Thioredoxin Systems is .

  • How much funding has Thioredoxin Systems raised over time?

    Thioredoxin Systems has raised $3.45M.

  • Who are Thioredoxin Systems’s investors?

    Annexstruktur AB, GOBIA Enterprises, GU Ventures, , and are 5 of 6 investors who have invested in Thioredoxin Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process